Literature DB >> 18539544

Use of critical care resources after laparoscopic gastric bypass: effect on respiratory complications.

Hanan El Shobary1, Steven Backman, Nicolas Christou, Thomas Schricker.   

Abstract

BACKGROUND: Before 2005, all subjects undergoing laparoscopic gastric bypass with a body mass index >50 kg/m(2), age >40 years, and documented obstructive sleep apnea (OSA) were admitted to the intensive care unit (ICU) in our institution. Starting in January 2005, only patients with a body mass index >60 kg/m(2) and severe OSA were admitted. This study assessed the incidence of respiratory complications in patients undergoing laparoscopic gastric bypass before and after implementation of the new ICU admission criteria.
METHODS: The records of the laparoscopic gastric bypass patients who had undergone laparoscopic gastric bypass from January 2004 to December 2005 were reviewed regarding demographic data (age, sex, body mass index, American Society of Anesthesiologists classification); OSA; use of home continuous positive airway pressure; length of stay in postanesthesia care unit, ICU, and hospital; postoperative ventilation and hypoxemia (oxygen saturation <90%), and unplanned ICU admission.
RESULTS: A total of 250 charts were analyzed (122 from 2004 and 128 from 2005). The demographic data were comparable between the 2 groups. Although OSA was more frequent in the 2004 than in the 2005 cohort (P = .02), the incidence of OSA requiring home continuous positive airway pressure was comparable (P = .47). The length of hospital stay was greater in 2004 than in 2005 (P = .003). More patients were admitted to the ICU in 2004 (P <.001). All unplanned ICU admissions were because of surgical anastomotic/staple line leaks (7 patients in 2004 versus 0 in 2005; P = .006). Overall, the incidence of postoperative respiratory complications was low (6% in 2004 and 4% in 2005) and comparable in both groups.
CONCLUSION: Limiting ICU admission after laparoscopic gastric bypass to patients with a body mass index >60 kg/m(2) and severe OSA did not increase the overall incidence of postoperative respiratory complications or hospital stay.

Entities:  

Mesh:

Year:  2008        PMID: 18539544     DOI: 10.1016/j.soard.2008.02.003

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  4 in total

1.  Safety of Continuous Postoperative Pulse Oximetry Monitoring Without Obstructive Sleep Apnea Screening in > 5000 Patients Undergoing Bariatric Surgery.

Authors:  Sophie L van Veldhuisen; Ibrahim Arslan; Laura N Deden; Edo O Aarts; Eric J Hazebroek
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

2.  Routine Postoperative Monitoring after Bariatric Surgery in Morbidly Obese Patients with Severe Obstructive Sleep Apnea: ICU Admission is not Necessary.

Authors:  Amin B Goucham; Usha K Coblijn; Helga B Hart-Sweet; Nico de Vries; Sjoerd M Lagarde; Bart A van Wagensveld
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

3.  Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP.

Authors:  Nicola Di Lorenzo; Stavros A Antoniou; Rachel L Batterham; Luca Busetto; Daniela Godoroja; Angelo Iossa; Francesco M Carrano; Ferdinando Agresta; Isaias Alarçon; Carmil Azran; Nicole Bouvy; Carmen Balaguè Ponz; Maura Buza; Catalin Copaescu; Maurizio De Luca; Dror Dicker; Angelo Di Vincenzo; Daniel M Felsenreich; Nader K Francis; Martin Fried; Berta Gonzalo Prats; David Goitein; Jason C G Halford; Jitka Herlesova; Marina Kalogridaki; Hans Ket; Salvador Morales-Conde; Giacomo Piatto; Gerhard Prager; Suzanne Pruijssers; Andrea Pucci; Shlomi Rayman; Eugenia Romano; Sergi Sanchez-Cordero; Ramon Vilallonga; Gianfranco Silecchia
Journal:  Surg Endosc       Date:  2020-04-23       Impact factor: 4.584

4.  Clinical and critical care concerns in severely ill obese patient.

Authors:  Sukhminder Jit Singh Bajwa; Vishal Sehgal; Sukhwinder Kaur Bajwa
Journal:  Indian J Endocrinol Metab       Date:  2012-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.